X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (370) 370
Patent (66) 66
Publication (35) 35
Book Chapter (4) 4
Book / eBook (3) 3
Conference Proceeding (3) 3
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (199) 199
index medicus (95) 95
hematology (83) 83
oncology (73) 73
imatinib mesylate (69) 69
chemistry (65) 65
metallurgy (65) 65
human necessities (64) 64
hygiene (64) 64
medical or veterinary science (64) 64
preparations for medical, dental, or toilet purposes (64) 64
female (61) 61
male (61) 61
organic chemistry (59) 59
animals (57) 57
middle aged (55) 55
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (51) 51
benzamides (50) 50
antineoplastic agents - therapeutic use (49) 49
chronic myelogenous leukemia (49) 49
aged (48) 48
adult (47) 47
mice (47) 47
heterocyclic compounds (42) 42
leukemia (42) 42
cancer (41) 41
chronic myeloid leukemia (36) 36
pyrimidines - therapeutic use (36) 36
hemic and lymphatic diseases (35) 35
cell line, tumor (34) 34
mutation (33) 33
piperazines - therapeutic use (33) 33
specific therapeutic activity of chemical compounds ormedicinal preparations (33) 33
chronic myeloid-leukemia (31) 31
imatinib (31) 31
therapy (27) 27
tyrosine kinase (27) 27
aged, 80 and over (26) 26
bcr-abl (25) 25
biochemistry & molecular biology (25) 25
dasatinib (25) 25
protein kinase inhibitors - pharmacology (25) 25
treatment outcome (25) 25
antineoplastic agents - pharmacology (24) 24
leukemia, myelogenous, chronic, bcr-abl positive - genetics (24) 24
protein kinase inhibitors - therapeutic use (24) 24
pyrimidines - pharmacology (24) 24
piperazines - pharmacology (22) 22
antineoplastic agents - adverse effects (21) 21
expression (21) 21
peptides (21) 21
tumor cells, cultured (21) 21
drug resistance, neoplasm (20) 20
fusion proteins, bcr-abl - genetics (20) 20
tyrosine (20) 20
analysis (19) 19
apoptosis (19) 19
cell line (19) 19
gene (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - pathology (19) 19
research (19) 19
tyrosine kinase inhibitor (19) 19
adolescent (18) 18
follow-up studies (18) 18
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (18) 18
pyrimidines - adverse effects (18) 18
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (17) 17
aniline compounds - therapeutic use (17) 17
biochemistry (17) 17
cell biology (17) 17
follow-up (17) 17
nitriles - therapeutic use (17) 17
piperazines - adverse effects (17) 17
protein-tyrosine kinases - antagonists & inhibitors (17) 17
quinolines - therapeutic use (17) 17
molecular sequence data (16) 16
piperazines - administration & dosage (16) 16
pyrimidines - administration & dosage (16) 16
resistance (16) 16
fusion proteins, bcr-abl - metabolism (15) 15
kinases (15) 15
patients (15) 15
phosphorylation (15) 15
prognosis (15) 15
protein-tyrosine kinases - metabolism (15) 15
research article (15) 15
apoptosis - drug effects (14) 14
article (14) 14
beer (14) 14
bosutinib (14) 14
compositions or test papers therefor (14) 14
compositions thereof (14) 14
condition-responsive control in microbiological orenzymological processes (14) 14
culture media (14) 14
cytotoxicity, immunologic (14) 14
drug resistance (14) 14
enzymology (14) 14
immunotherapy (14) 14
investigating or analysing materials by determining theirchemical or physical properties (14) 14
leukemia, myeloid, chronic-phase - drug therapy (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (433) 433
French (32) 32
German (19) 19
Italian (4) 4
Portuguese (3) 3
Danish (2) 2
Chinese (1) 1
Polish (1) 1
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 2017, Volume 102, Issue 1, pp. 4 - 6
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2015, Volume 90, Issue 2, pp. 156 - 161
Journal Article
Frontiers in Bioscience - Elite, ISSN 1945-0494, 2016, Volume 8, Issue 1, pp. 46 - 60
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 01/2017, Volume 102, Issue 1, pp. 4 - 6
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 8, pp. 775 - 776
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 902 - 902
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 1, pp. 95 - 96
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 22, pp. 3616 - 3627
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2016, Volume 91, Issue 1, pp. 67 - 75
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2018, Volume 36, Issue 3, pp. 231 - 237
Purpose Bosutinib is a potent dual SRC/ABL kinase inhibitor approved for adults with Philadelphia chromosome-positive chronic myeloid leukemia (CML) resistant... 
TREATMENT-FREE REMISSION | 24-MONTH FOLLOW-UP | ONCOLOGY | SAFETY | RESISTANCE | INTOLERANCE | DASATINIB | OUTCOMES | LONG-TERM EFFICACY | Index Medicus | ORIGINAL REPORTS
Journal Article
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, p. djt378
Journal Article